Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Pharmaceuticals (Basel, Switzerland)|February 27, 2026
Frontiers in Rheumatoid Arthritis: Emerging Research and Unmet Needs in Pharmacologic ManagementJoshua J Skydel, Betty Hsiao
Current Opinion in Rheumatology|February 13, 2019
Patient preferences for rheumatoid arthritis treatmentBetty Hsiao, Liana Fraenkel
Current Opinion in Rheumatology|January 11, 2017
Incorporating the patient's perspective in outcomes researchBetty Hsiao, Liana Fraenkel
Cureus|March 24, 2026
A Unique Case of Granulomatosis With Polyangiitis With Cutaneous Manifestations Developing a Decade LaterSophia E Kujawski, Betty Hsiao
JAMA Network Open|May 11, 2019
Analysis of Postapproval Clinical Trials of Therapeutics Approved by the US Food and Drug Administration Without Clinical Postmarketing Requirements or CommitmentsJoshua J Skydel, Anita T Luxkaranayagam, Sanket S Dhruva, et al.
BMJ Medicine|April 10, 2024
Characterization of accelerated approval status, trial endpoints and results, and recommendations in guidelines for oncology drug treatments from the National Comprehensive Cancer Network: cross sectional studyMaryam Mooghali, Aaron P Mitchell, Joshua J Skydel, et al.
Infectious Disease Clinics of North America|April 27, 2020
Vaccinations and BiologicsBetty Hsiao, Aisha Khan, Insoo Kang
Clinical Trials (London, England)|April 17, 2021
US Food and Drug Administration utilization of postmarketing requirements and postmarketing commitments, 2009-2018Joshua J Skydel, Audrey D Zhang, Sanket S Dhruva, et al.
BMJ (Clinical Research Ed.)|May 10, 2022
Agreement of treatment effects from observational studies and randomized controlled trials evaluating hydroxychloroquine, lopinavir-ritonavir, or dexamethasone for covid-19: meta-epidemiological studyOsman Moneer, Garrison Daly, Joshua J Skydel, et al.
JAMA Health Forum|August 17, 2022
Spending by the Centers for Medicare & Medicaid Services Before and After Confirmation of Benefit for Drugs Granted US Food and Drug Administration Accelerated Approval, 2012 to 2017Joshua J Skydel, Alexander C Egilman, Joshua D Wallach, et al.
Pageof 2